Monterey Bio Acquisition Stock Fundamentals
| MTRYWDelisted Stock | USD 0.03 0.00 0.00% |
Monterey Bio Acquisition fundamentals help investors to digest information that contributes to Monterey Bio's financial success or failures. It also enables traders to predict the movement of Monterey Stock. The fundamental analysis module provides a way to measure Monterey Bio's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Monterey Bio stock.
Monterey |
Monterey Bio Acquisition Company EBITDA Analysis
Monterey Bio's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Current Monterey Bio EBITDA | (2.04 M) |
Most of Monterey Bio's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Monterey Bio Acquisition is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
CompetitionAccording to the company disclosure, Monterey Bio Acquisition reported earnings before interest,tax, depreciation and amortization of (2.04 Million). This is 100.0% lower than that of the Capital Markets sector and significantly lower than that of the Financials industry. The ebitda for all United States stocks is 100.05% higher than that of the company.
Monterey Bio Acquisition Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Monterey Bio's current stock value. Our valuation model uses many indicators to compare Monterey Bio value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Monterey Bio competition to find correlations between indicators driving Monterey Bio's intrinsic value. More Info.Monterey Bio Acquisition is regarded third in number of shares shorted category among its peers. It also is regarded third in ebitda category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value Monterey Bio by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Monterey EBITDA Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Monterey Bio's direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Monterey Bio could also be used in its relative valuation, which is a method of valuing Monterey Bio by comparing valuation metrics of similar companies.Monterey Bio is currently under evaluation in ebitda category among its peers.
Monterey Fundamentals
| Number Of Shares Shorted | 29.57 K | |||
| EBITDA | (2.04 M) | |||
| Net Income | (1.27 M) | |||
| Cash And Equivalents | 6.76 K | |||
| Total Debt | 175.41 K | |||
| Debt To Equity | 7.37 % | |||
| Current Ratio | 25.00 X | |||
| Book Value Per Share | 0.01 X | |||
| Cash Flow From Operations | (1 M) | |||
| Total Asset | 21.42 M | |||
| Retained Earnings | (1.86 M) | |||
| Working Capital | (1.29 M) | |||
| Z Score | -0.51 | |||
| Net Asset | 21.42 M |
About Monterey Bio Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Monterey Bio Acquisition's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Monterey Bio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Monterey Bio Acquisition based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Monterey Bio Acquisition Corporation focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. Monterey Bio Acquisition Corporation was incorporated in 2020 and is based in New York, New York. Monterey Bio operates under Shell Companies classification in the United States and is traded on NASDAQ Exchange.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Other Consideration for investing in Monterey Stock
If you are still planning to invest in Monterey Bio Acquisition check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Monterey Bio's history and understand the potential risks before investing.
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Stocks Directory Find actively traded stocks across global markets | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon |